Cansino Biologics Inc.

This early-stage trial tests a new vaccine that combines protection against diphtheria, tetanus, whooping cough, meningitis, and Hib in one shot. About 260 children aged 2 months to 6 years will receive different doses or a placebo to check safety and immune response. The goal is…

This study tests a new vaccine (PCV13i) to see if it safely protects healthy infants from serious bacterial infections like pneumonia and meningitis. About 600 babies in Thailand will receive either the new vaccine or a standard one at 2 months, 4 months, and 12-15 months old. Re…